PPARɑ变体V227A通过增强的脂蛋白脂解来降低血甘油三
Lauren F Uchiyama1, Gabriel P M Ordonez2, Khoi T Pham2
1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA; Department of Biological Chemistry, University of California, Los Angeles, CA.
Journal of lipid research
|April 17, 2025
概括
人类变异的氧酶增殖器激活受体-α (PPARɑ) 影响新陈代谢. 一种V227A变异的小鼠模型显示,通过增强肝脏和心脏中甘油三液解的基因表达来降低甘油三.
科学领域:
- 代谢研究的研究.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 人类单核酸变异在氧酶增殖器激活受体-α (PPARɑ) 与有利的代谢特征有关.
- 这些变异对代谢基因表达的确切影响尚不清楚.
研究的目的:
- 用小鼠模型研究人类PPARɑ变体 (V227A) 对全身新陈代谢的生理影响.
- 阐明与PPARɑ V227A变种相关的代谢表型背后的分子机制.
主要方法:
- 开发一种表达人类PPARɑ V227A变异的小鼠模型.
- 血甘油三,体质和肝脏脂质积累的分析.
- 在肝脏和心脏组织中的基因表达概况.
- 评估脂蛋白脂酶 (Lpl) 表达和活性.
主要成果:
- 携带V227A变异的小鼠表现出血甘油三降低,而体质或肝脂质没有变化.
- 基因表达分析显示,变种小鼠的肝脏中增强了PPARɑ目标基因表达.
- 观察到Lpl的肝脏和心脏表达增加,以及心脏中增强的甘油三液解活性.
结论:
- 该PPARɑ V227A变体增强了全身甘油三清除,主要是通过增加Lpl表达在肝脏和心脏.
- 这些发现为携带V227A PPARɑ变体的人群中观察到的有益代谢表型提供了机制性的解释.
- 这项研究验证了人类观察数据,并阐明了这种特定的PPARɑ变体的生理作用.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Cholesterol: Significance and Regulation
519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
519
Glucagon-like Receptor Agonists
305
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
305
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


